Daniela Gabbia

1.3k total citations
59 papers, 988 citations indexed

About

Daniela Gabbia is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Daniela Gabbia has authored 59 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 18 papers in Hepatology and 13 papers in Molecular Biology. Recurrent topics in Daniela Gabbia's work include Liver Disease Diagnosis and Treatment (23 papers), Liver Diseases and Immunity (9 papers) and Drug Transport and Resistance Mechanisms (7 papers). Daniela Gabbia is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Liver Diseases and Immunity (9 papers) and Drug Transport and Resistance Mechanisms (7 papers). Daniela Gabbia collaborates with scholars based in Italy, Ecuador and Switzerland. Daniela Gabbia's co-authors include Sara De Martin, Maria Carrara, Annarosa Floreani, Francesco Paolo Russo, Yahima Frión-Herrera, Osmany Cuesta‐Rubio, Sara Bogialli, Maria Guido, Marco Roverso and Nicola Ferri and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Daniela Gabbia

56 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Gabbia Italy 22 325 264 200 134 118 59 988
Tin K. Mao United States 16 260 0.8× 296 1.1× 257 1.3× 92 0.7× 47 0.4× 23 1.3k
Lei Dong China 16 216 0.7× 424 1.6× 111 0.6× 62 0.5× 55 0.5× 42 1.0k
Karina Reyes‐Gordillo United States 18 346 1.1× 308 1.2× 256 1.3× 85 0.6× 61 0.5× 28 1.1k
Vicente Sánchez-Valle Mexico 8 328 1.0× 181 0.7× 238 1.2× 89 0.7× 76 0.6× 15 782
Verónica Souza Mexico 20 255 0.8× 280 1.1× 148 0.7× 68 0.5× 91 0.8× 34 927
Xin Han China 20 258 0.8× 460 1.7× 130 0.7× 73 0.5× 87 0.7× 59 1.1k
Xiaoli Ma China 18 220 0.7× 277 1.0× 42 0.2× 109 0.8× 43 0.4× 49 856
Marina Galicia‐Moreno Mexico 17 306 0.9× 262 1.0× 151 0.8× 95 0.7× 46 0.4× 32 841
Erika Ramos‐Tovar Mexico 16 491 1.5× 280 1.1× 289 1.4× 162 1.2× 21 0.2× 27 962

Countries citing papers authored by Daniela Gabbia

Since Specialization
Citations

This map shows the geographic impact of Daniela Gabbia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Gabbia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Gabbia more than expected).

Fields of papers citing papers by Daniela Gabbia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Gabbia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Gabbia. The network helps show where Daniela Gabbia may publish in the future.

Co-authorship network of co-authors of Daniela Gabbia

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Gabbia. A scholar is included among the top collaborators of Daniela Gabbia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Gabbia. Daniela Gabbia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abalo, Raquel, et al.. (2025). Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies. International Journal of Molecular Sciences. 26(19). 9345–9345. 1 indexed citations
2.
Cuffaro, Doretta, Adriana Chilin, Marco Macchia, et al.. (2025). Oleocanthalic acid improves MASH features via a NOX1-dependent mechanism. European Journal of Pharmacology. 1002. 177847–177847. 1 indexed citations
3.
Gabbia, Daniela, et al.. (2024). Tyrosol attenuates NASH features by reprogramming the hepatic immune milieu. European Journal of Pharmacology. 969. 176453–176453. 11 indexed citations
5.
Floreani, Annarosa, Daniela Gabbia, & Sara De Martin. (2024). Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences. 25(4). 2194–2194. 5 indexed citations
7.
Gabbia, Daniela, et al.. (2024). Sex-dependent effects of the uncompetitive N-methyl-D-aspartate receptor antagonist REL-1017 in G93A-SOD1 amyotrophic lateral sclerosis mice. Frontiers in Neurology. 15. 1384829–1384829. 1 indexed citations
8.
Grigoletto, Antonella, Laura Cannella, Daniela Gabbia, et al.. (2024). Optimization of a pendant-shaped PEGylated linker for antibody-drug conjugates. Journal of Controlled Release. 375. 74–89. 7 indexed citations
9.
Grigoletto, Antonella, Giuseppe Toffoli, Delia Mandracchia, et al.. (2023). Anti‐HER2 Super Stealth Immunoliposomes for Targeted‐Chemotherapy. Advanced Healthcare Materials. 12(29). e2301650–e2301650. 15 indexed citations
10.
Gabbia, Daniela & Sara De Martin. (2023). Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma. International Journal of Molecular Sciences. 24(4). 3441–3441. 25 indexed citations
11.
Gabbia, Daniela & Sara De Martin. (2023). Targeting the Adipose Tissue–Liver–Gut Microbiota Crosstalk to Cure MASLD. Biology. 12(12). 1471–1471. 13 indexed citations
12.
Floreani, Annarosa, Daniela Gabbia, & Sara Martin. (2023). Update on Epidemiology of IgG4-related Disease Involving the Liver and Pancreas. Medical Research Archives. 11(2). 1 indexed citations
13.
Franceschinis, Erica, Marco Roverso, Daniela Gabbia, et al.. (2022). Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis. Pharmaceutics. 14(9). 1806–1806. 9 indexed citations
14.
Gabbia, Daniela, Sara Carpi, Samantha Sarcognato, et al.. (2022). The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs. Biomedicine & Pharmacotherapy. 157. 114014–114014. 23 indexed citations
15.
Martin, Sara De, Daniela Gabbia, Sara Bogialli, et al.. (2021). Refill liquids for electronic cigarettes display peculiar toxicity on human endothelial cells. Toxicology Reports. 8. 456–462. 3 indexed citations
16.
Frión-Herrera, Yahima, Daniela Gabbia, Osmany Cuesta‐Rubio, Sara De Martin, & Maria Carrara. (2019). Nemorosone inhibits the proliferation and migration of hepatocellular carcinoma cells. Life Sciences. 235. 116817–116817. 22 indexed citations
17.
Frión-Herrera, Yahima, et al.. (2019). Chemosensitizing activity of Cuban propolis and nemorosone in doxorubicin resistant human colon carcinoma cells. Fitoterapia. 136. 104173–104173. 31 indexed citations
18.
Gabbia, Daniela, Luisa Pozzo, Marco Roverso, et al.. (2018). Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation. PLoS ONE. 13(9). e0204336–e0204336. 51 indexed citations
19.
Buriani, Alessandro, Stefano Fortinguerra, Vincenzo Sorrenti, et al.. (2017). Human Adenocarcinoma Cell Line Sensitivity to Essential Oil Phytocomplexes from Pistacia Species: a Multivariate Approach. Molecules. 22(8). 1336–1336. 28 indexed citations
20.
Gabbia, Daniela, Roberta Lazzari, Maria Carrara, et al.. (2017). Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis. World Journal of Gastroenterology. 23(42). 7519–7530. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026